Find uplifting stories about heroes, innovations, and solutions
3672 results for "vaccine trials"
Scientists at La Jolla Institute and Scripps Research have created an HIV vaccine that triggered the strongest antibody response ever seen in primates. Human trials are now underway for a vaccine 14 years in the making.
A new therapeutic vaccine targeting acne-causing bacteria has entered clinical trials in China, offering hope for millions who struggle with treatment-resistant breakouts. The protein-based shot marks a global shift toward immune-based solutions for the world's eighth most common skin condition.
Scientists at the University of Guelph have successfully tested the world's first vaccine against Campylobacter jejuni, a bacterial infection that causes millions of cases of severe diarrhea worldwide each year. The Phase 1 trial showed the vaccine is safe and triggers strong immune responses at even low doses.
Britain just launched a groundbreaking 24-week trial to vaccinate turkeys against bird flu, a disease that's cost the government and poultry industry up to £174 million annually. This marks a major shift in strategy that could protect food supplies and prevent devastating flock losses.
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
For the first time in decades, a vaccine to prevent Lyme disease is showing real promise. Pfizer's new vaccine candidate demonstrated over 75% effectiveness in a major clinical trial, offering hope to millions who spend time outdoors.
%2Ffile%2Fattachments%2Forphans%2F2HIVVaccineResearch_437240.jpg)
When the US pulled funding for a groundbreaking HIV vaccine trial in Cape Town, South African scientists refused to quit. They found new backers and launched a scaled-down version that could reinvigorate global vaccine research.
A deadly tropical virus with up to 75% fatality rates finally has a vaccine candidate heading to human trials. Tokyo researchers modified the measles vaccine to protect against Nipah virus, which has killed dozens in recent outbreaks.
University of Guelph researchers just cleared a major hurdle on a 20-year quest to create the world's first vaccine against campylobacter jejuni, the number one bacterial cause of severe diarrhea worldwide. The phase one human trial proved the vaccine is safe and effective at building immunity.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
Scientists in Japan are launching the first human trial of a Nipah vaccine in April, targeting a virus that kills up to 75% of those infected. With no current treatment available, this breakthrough could save thousands of lives in regions where outbreaks occur.
Ethiopia just became only the second African nation to successfully complete a Phase II Marburg virus vaccine trial during an active outbreak. The breakthrough signals a major leap in the country's scientific capacity and readiness to tackle future health emergencies.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
South Africa just enrolled its first participant in a groundbreaking HIV vaccine trial designed specifically for African strains of the virus. This time, African scientists are leading the charge.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, helped patients live twice as long as usual in a groundbreaking trial. One patient remains cancer-free nearly five years later.
%2Ffile%2Fattachments%2Forphans%2FProfessorWillemHanekom_276321.jpeg)
Professor Willem Hanekom is co-leading a 20,000-person global trial for the world's most promising TB vaccine while directing Africa's largest health research institute. Living openly with HIV for 19 years, he's dedicated his career to bringing life-saving treatments to underresourced communities.
Scientists just proved that an AI-designed vaccine can trigger a human immune response, marking the first time a computer-created vaccine has worked in people. This breakthrough could revolutionize how we develop vaccines for future diseases.
A new flu vaccine using the same technology that powered COVID shots just proved more effective than traditional options in a 40,000-person study. The breakthrough could reshape how we protect ourselves from seasonal flu.
A groundbreaking HIV vaccine study in Cape Town is moving forward after South African researchers regrouped when US funding vanished. The trial tests a novel approach that could finally unlock the key to preventing HIV.
Showing 20 of 3672